159 related articles for article (PubMed ID: 1382336)
1. Structural basis of voltage-gated K+ channel pharmacology.
Pongs O
Trends Pharmacol Sci; 1992 Sep; 13(9):359-65. PubMed ID: 1382336
[TBL] [Abstract][Full Text] [Related]
2. Receptor sites for open channel blockers of Shaker voltage-gated potassium channels--molecular approaches.
Pongs O
J Recept Res; 1993; 13(1-4):503-12. PubMed ID: 7680721
[TBL] [Abstract][Full Text] [Related]
3. Alternative Shaker transcripts express either rapidly inactivating or noninactivating K+ channels.
Stocker M; Stühmer W; Wittka R; Wang X; Müller R; Ferrus A; Pongs O
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8903-7. PubMed ID: 1701056
[TBL] [Abstract][Full Text] [Related]
4. Noxiustoxin and leiurutoxin III, two homologous peptide toxins with binding properties to synaptosomal membrane K+ channels.
Valdivia HH; Martin BM; Escobar L; Possani LD
Biochem Int; 1992 Sep; 27(6):953-62. PubMed ID: 1280139
[TBL] [Abstract][Full Text] [Related]
5. Tityustoxin-K alpha, a structurally novel and highly potent K+ channel peptide toxin, interacts with the alpha-dendrotoxin binding site on the cloned Kv1.2 K+ channel.
Werkman TR; Gustafson TA; Rogowski RS; Blaustein MP; Rogawski MA
Mol Pharmacol; 1993 Aug; 44(2):430-6. PubMed ID: 8355670
[TBL] [Abstract][Full Text] [Related]
6. Interactions between dendrotoxin, a blocker of voltage-dependent potassium channels, and charybdotoxin, a blocker of calcium-activated potassium channels, at binding sites on neuronal membranes.
Harvey AL; Marshall DL; De-Allie FA; Strong PN
Biochem Biophys Res Commun; 1989 Aug; 163(1):394-7. PubMed ID: 2476127
[TBL] [Abstract][Full Text] [Related]
7. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
[TBL] [Abstract][Full Text] [Related]
8. Tityustoxin K alpha blocks voltage-gated noninactivating K+ channels and unblocks inactivating K+ channels blocked by alpha-dendrotoxin in synaptosomes.
Rogowski RS; Krueger BK; Collins JH; Blaustein MP
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1475-9. PubMed ID: 7509073
[TBL] [Abstract][Full Text] [Related]
9. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
Gao YD; Garcia ML
Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular effects of some potassium channel blocking toxins from the venom of the scorpion Leiurus quinquestriatus hebreus.
Marshall DL; Vatanpour H; Harvey AL; Boyot P; Pinkasfeld S; Doljansky Y; Bouet F; Ménez A
Toxicon; 1994 Nov; 32(11):1433-43. PubMed ID: 7533951
[TBL] [Abstract][Full Text] [Related]
11. Kaliotoxin, a novel peptidyl inhibitor of neuronal BK-type Ca(2+)-activated K+ channels characterized from Androctonus mauretanicus mauretanicus venom.
Crest M; Jacquet G; Gola M; Zerrouk H; Benslimane A; Rochat H; Mansuelle P; Martin-Eauclaire MF
J Biol Chem; 1992 Jan; 267(3):1640-7. PubMed ID: 1730708
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
13. Developmental analysis reveals mismatches in the expression of K+ channel alpha subunits and voltage-gated K+ channel currents in rat ventricular myocytes.
Xu H; Dixon JE; Barry DM; Trimmer JS; Merlie JP; McKinnon D; Nerbonne JM
J Gen Physiol; 1996 Nov; 108(5):405-19. PubMed ID: 8923266
[TBL] [Abstract][Full Text] [Related]
14. Charybdotoxin, dendrotoxin and mast cell degranulating peptide block the voltage-activated K+ current of fibroblast cells stably transfected with NGK1 (Kv1.2) K+ channel complementary DNA.
Werkman TR; Kawamura T; Yokoyama S; Higashida H; Rogawski MA
Neuroscience; 1992 Oct; 50(4):935-46. PubMed ID: 1280351
[TBL] [Abstract][Full Text] [Related]
15. Effects of charybdotoxin on K+ channel (KV1.2) deactivation and inactivation kinetics.
Sprunger LK; Stewig NJ; O'Grady SM
Eur J Pharmacol; 1996 Oct; 314(3):357-64. PubMed ID: 8957259
[TBL] [Abstract][Full Text] [Related]
16. Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor.
MacKinnon R; Heginbotham L; Abramson T
Neuron; 1990 Dec; 5(6):767-71. PubMed ID: 1702643
[TBL] [Abstract][Full Text] [Related]
17. Toxins in the characterization of potassium channels.
Castle NA; Haylett DG; Jenkinson DH
Trends Neurosci; 1989 Feb; 12(2):59-65. PubMed ID: 2469212
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular evidence for Shaker-like K+ channels in rabbit renal papillary epithelial cell line.
Volk KA; Husted RF; Pruchno CJ; Stokes JB
Am J Physiol; 1994 Oct; 267(4 Pt 2):F671-8. PubMed ID: 7524363
[TBL] [Abstract][Full Text] [Related]
19. An emerging pharmacology of peptide toxins targeted against potassium channels.
Moczydlowski E; Lucchesi K; Ravindran A
J Membr Biol; 1988 Oct; 105(2):95-111. PubMed ID: 2464066
[TBL] [Abstract][Full Text] [Related]
20. Voltage-gated potassium channels in brown fat cells.
Lucero MT; Pappone PA
J Gen Physiol; 1989 Mar; 93(3):451-72. PubMed ID: 2467964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
